Altshuler Shaham Ltd Cuts Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Altshuler Shaham Ltd trimmed its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 37.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 84,739 shares of the company’s stock after selling 51,609 shares during the quarter. Altshuler Shaham Ltd’s holdings in Takeda Pharmaceutical were worth $1,209,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sage Rhino Capital LLC boosted its position in Takeda Pharmaceutical by 7.6% during the third quarter. Sage Rhino Capital LLC now owns 11,751 shares of the company’s stock worth $182,000 after acquiring an additional 831 shares during the last quarter. Legacy Wealth Asset Management LLC lifted its holdings in Takeda Pharmaceutical by 0.7% in the third quarter. Legacy Wealth Asset Management LLC now owns 124,967 shares of the company’s stock valued at $1,933,000 after acquiring an additional 851 shares during the last quarter. Vestmark Advisory Solutions Inc. grew its position in Takeda Pharmaceutical by 1.4% in the third quarter. Vestmark Advisory Solutions Inc. now owns 63,630 shares of the company’s stock worth $984,000 after acquiring an additional 870 shares during the period. Cambridge Investment Research Advisors Inc. raised its position in Takeda Pharmaceutical by 5.7% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 16,433 shares of the company’s stock valued at $254,000 after purchasing an additional 883 shares during the period. Finally, Lindbrook Capital LLC lifted its stake in shares of Takeda Pharmaceutical by 40.6% in the 4th quarter. Lindbrook Capital LLC now owns 4,065 shares of the company’s stock valued at $58,000 after purchasing an additional 1,174 shares during the last quarter. Institutional investors and hedge funds own 9.17% of the company’s stock.

Takeda Pharmaceutical Trading Up 2.5 %

Shares of NYSE:TAK traded up $0.32 during midday trading on Thursday, reaching $13.38. 2,941,880 shares of the company’s stock were exchanged, compared to its average volume of 1,792,912. The firm’s 50 day simple moving average is $13.82 and its two-hundred day simple moving average is $14.09. Takeda Pharmaceutical Company Limited has a fifty-two week low of $12.77 and a fifty-two week high of $17.03. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.06 and a quick ratio of 0.55. The stock has a market cap of $42.35 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 3.05 and a beta of 0.56.

Takeda Pharmaceutical Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.